{"id":1015201,"date":"2026-10-29T12:19:28","date_gmt":"2026-10-29T16:19:28","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/"},"modified":"2026-10-29T12:19:28","modified_gmt":"2026-10-29T16:19:28","slug":"annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/","title":{"rendered":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026"},"content":{"rendered":"<h2>\nMaria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>MALVERN, Pa., Oct.  29, 2026  (GLOBE NEWSWIRE) &#8212; Annovis Bio, Inc. (NYSE: ANVS) (\u201cAnnovis\u201d or the \u201cCompany\u201d), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), today announced that Maria Maccecchini, PhD, Founder, President and CEO of Annovis, will participate and present in two industry events in November.<\/p>\n<p>\n        <strong>U.S. Biotech Day 2026<\/strong> | November 16\u201317, 2026 | Philadelphia, PA<\/p>\n<ul type=\"disc\">\n<li>Panel<strong>:<\/strong> \u201cBridging the Translational Gap: From Discovery Insights to Clinical Proof\u201d, November 16, 9:15\u20139:45 a.m. ET<\/li>\n<li>Company showcase: November 16, 10:15\u201310:30 a.m. ET<\/li>\n<\/ul>\n<p>At <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UApRwDj2KnW7zcdNYdtxLpVd0qMNcxXrW-X73fbOIAFVwQ2sw7FBR4_ZCJwkAqENdEaoLCIGzIsSApSeP2EzgrRw7QVPIBT9Gvt5rPgEjjU=\" rel=\"nofollow\" target=\"_blank\">U.S. Biotech Day 2026<\/a>, Dr. Maccecchini will join a panel of leaders from Pfizer, Merck, Bristol Myers Squibb, Boehringer Ingelheim and other pharmaceutical companies to discuss how discovery-stage insights translate into clinical proof. She will also deliver a company presentation highlighting Annovis\u2019 clinical programs and upcoming milestones.<\/p>\n<p>\n        <strong>Pharma Partnering Summit 2026<\/strong> | November 19\u201320, 2026 | Boston, MA<\/p>\n<ul type=\"disc\">\n<li>Company presentation: \u201cRestoring Proteostasis in Alzheimer\u2019s and Parkinson\u2019s Diseases with Buntanetap, a Translational Inhibitor of Neurotoxic Proteins\u201d,\u00a0November 19, 11:25\u201311:55 a.m. ET<\/li>\n<\/ul>\n<p>At <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-MkS4WumV8xJzApxDnr_fx9HuUsYPCjyN3fTa9mJhi3Ejj4QfTH3hrZOrEY8U4b_ZVUL1tP_pfy1EFVM41H9kIjhu7t5cCbUkMSYyId4D9msB8zFdYqu0kcMtIq7g40170t73ITJnH-XTKShai-YTw==\" rel=\"nofollow\" target=\"_blank\">Pharma Partnering Summit 2026<\/a>, Dr. Maccecchini will present Annovis\u2019 clinical progress and meet with biotech and pharma representatives.<\/p>\n<p>During both events, Dr. Maccecchini will also hold one-on-one meetings with industry leaders. Attendees interested in scheduling a meeting may do so through each event\u2019s partnering system or by contacting us at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AMt-XAjR5ECWWp1ER5M3es6hOv8GtjF3gvEEj8zwdfhR_-4ZxxlCurzESWYp9GWX6wGwlS8Dtvq5fY2Wsag5Ysm1MkO7lRhf0i2gu-FpRh8=\" rel=\"nofollow\" target=\"_blank\">ir@annovisbio.com<\/a>.<\/p>\n<p>\n        <strong>About Annovis<\/strong><br \/>\n        <br \/>Headquartered in Malvern, Pennsylvania, Annovis Bio, Inc. (NYSE: ANVS) is a Phase 3 clinical-stage biotechnology company developing treatments for neurodegenerative diseases such as Alzheimer&#8217;s disease (AD) and Parkinson&#8217;s disease (PD). The Company&#8217;s lead drug candidate, buntanetap (formerly posiphen), is an investigational once-daily oral therapy that inhibits the translation of multiple neurotoxic proteins, including APP and amyloid beta, tau, alpha-synuclein, and TDP-43, through a specific RNA-targeting mechanism of action. By addressing the underlying causes of neurodegeneration, Annovis aims to halt disease progression and improve cognitive and motor functions in patients. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4bblhlRQ4R65OfAeZGHCn0xtcLCT_25PBYJzsZavEqTPC_rHqIpcSpTmdxba62Al1dwodaLoCVCeviJHHff7SQercpefrAixYkpeqtZGynJE5g6dZjEIBRrxiS-3qFuyM0DXWhlDc_GDPkAbdC8H1DCfvypLVOLT5eRE1UZEjpWW4CwJIwn5umjt9j56q1PIuDZ3C0mINde5ee28sqzuLmuubuX0KOad9MqArkHRpsbOVb9uWH-L1cip7BgrTaAbsW1CnCaOg9FQwPq6jzpPnQ==\" rel=\"nofollow\" target=\"_blank\">www.annovisbio.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JqsytC4eteRHP6aB3brGcJUzk3EfB6241ZhbBx6S1G4BZUKXPGCzgaFVGu_lJiOSAg2st23NYlbcGrBw_bmM7jYr_Mgq76mJFtzaVK47kVq8IMqSAoI_M_bQ4LZ_PA-ley15QBsUJeBdWpFVZJxg9bXcnwjlD7OIC2E9VhaYXznXTt7fgW6p0iBmvPOvUSgAawD-TQGV8Jjxu_fItA7ni5XkhP5T0hsJ54eswLFVBSTzXDr94FlO6OSregaQay0M3UpSYluMvu5KCautYuAj4toHr1gkXQX2fGRW35GKd3eMnevQhhuphhqWd9ks9abz\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cWVG14s-uLKgr7GZDbFaOy02jYnNBdkhw8X6lpSjWZ2_4i8X5gEkuqzkcA19V-xOlPNV41aCbqGKxtIzR7jj1-brm4gJud5Cx9V4tNX0ABlqI0EPk1O4gnbnRJF-UAy_7YpktpceeIaqIjeTfqkm9cK6BGk-e23GGV0_kZPdut9_QlI2ZqbY00XVPdmU06L-glkMbai5x8ULa3KrBhwNXm-Zv0KiuEarOzQZMt-Vv2rzmBrajEibNpBH6QbvPx7P\" rel=\"nofollow\" target=\"_blank\">YouTube<\/a>, and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-V5tfh-kUgrwheHZYJpuNYl7LLQH5jMmjRrTCNGTbTQoZe0WuiN2G8qFCg5rFheT-Tn0auXS9bFkRjV2S_n9CD-ZPx6rwd9qrqcTpNct9v1a8xD7RDP9K7UvGkTiPGUGGWfL2VxEQpqGK6BfK6Eu18C1SK5QUHfZ5rL0JwYkpEUx-2k1QZT4vtEnj1CHmK9OzLRnWR1hIXirKx-3WhtEQw==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Investor Alerts<\/strong><br \/>\n        <br \/>Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for email alerts at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uTaUTFVCGIMKBB7iN83EyL6XCJpzbTbVOk-2fbhKNqhhBGVnz02hKlEJBwtAtXGBprNK1Wc8ai7qortUEsF_epFfLm87GwlVvdtJqNGDVPTyHcuCHkkII_eHgfW_T7qhSDj-DAynmiGMzrNqA2huXzY3cCKNaI09mPR2VOKL19KbORBK5rlUPzf1sRTjsNvDQ3WChehdEHWdAO-J2W29t-at8EMf6XdQfaWpshb7b61mmCq5osSz94KOaSlPIJyYZXZ5iRwDfNKJJsAioE8rX35zgdQvtingDAM6VlfGHfzPLtMTRSxEdzdFo4JvhP3QXy2LcWkn2pdz6DCOCdb05np_t1JXxVgTLpA3oTKXsXA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.annovisbio.com\/email-alerts<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Actual results may differ due to various risks and uncertainties, including those outlined in the Company\u2019s SEC filings under \u201cRisk Factors\u201d in its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update forward-looking statements except as required by law.<\/p>\n<p>\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/>Annovis Bio Inc.<br \/>101 Lindenwood Drive<br \/>Suite 225<br \/>Malvern, PA 19355<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4bblhlRQ4R65OfAeZGHCn8jA6R6GYkesnBBop5oPRLYr5cp4THtwpcsPkVYl7licastzBU95IRe3lxNrCdBES5_MGIeWNRe9QfpqqwoxxWcRr5Klg8yFL85o0dz3Q8pUuda-V3yJB7IfzF-BM9FWWrawSErNpEwAB-5I-e4GhfqIWcslE09VSsLGUfBXy6XCShmqG2UeIuO2pXifQa7S2C8by7Cm6X3c5KPTf1zWd6k-8QG5S7RMbNlMjunY6T1JJQVUEht1lJc4aQ4LXNT-MQ==\" rel=\"nofollow\" target=\"_blank\">www.annovisbio.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Alexander Morin, Ph.D.<br \/>Director, Strategic Communications<br \/>Annovis Bio<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=AMt-XAjR5ECWWp1ER5M3euD6CQtgiHGtEeoPDifozVQD2ZlX4JwPbDHn7cGDb16x0gNzp8sqB6H-5h0pntSxGC4PQkMKpI4x49B3jHuJfOU=\" rel=\"nofollow\" target=\"_blank\">ir@annovisbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2U0ODQ5N2UtOThkNi00OTYyLWExNjUtMDQ1NWFmMjlmOGMzLTEyMDY0MDMtMjAyNi0xMC0yOS1lbg==\/tiny\/Annovis-Bio-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Annovis Bio, Inc. (NYSE: ANVS) (\u201cAnnovis\u201d or the \u201cCompany\u201d), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), today announced that Maria Maccecchini, PhD, Founder, President and CEO of Annovis, will participate and present in two industry events in November. U.S. Biotech Day 2026 | November 16\u201317, 2026 | Philadelphia, PA Panel: \u201cBridging the Translational Gap: From Discovery Insights to Clinical Proof\u201d, November 16, 9:15\u20139:45 a.m. ET Company showcase: November 16, 10:15\u201310:30 a.m. ET At U.S. Biotech Day 2026, Dr. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1015201","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Annovis Bio, Inc. (NYSE: ANVS) (\u201cAnnovis\u201d or the \u201cCompany\u201d), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), today announced that Maria Maccecchini, PhD, Founder, President and CEO of Annovis, will participate and present in two industry events in November. U.S. Biotech Day 2026 | November 16\u201317, 2026 | Philadelphia, PA Panel: \u201cBridging the Translational Gap: From Discovery Insights to Clinical Proof\u201d, November 16, 9:15\u20139:45 a.m. ET Company showcase: November 16, 10:15\u201310:30 a.m. ET At U.S. Biotech Day 2026, Dr. &hellip; Continue reading &quot;Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-29T16:19:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026\",\"datePublished\":\"2026-10-29T16:19:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/\"},\"wordCount\":481,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/\",\"name\":\"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\",\"datePublished\":\"2026-10-29T16:19:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/","og_locale":"en_US","og_type":"article","og_title":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk","og_description":"Maria Maccecchini, PhD, CEO of Annovis, will join industry panel with pharma leaders and present company updates MALVERN, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) &#8212; Annovis Bio, Inc. (NYSE: ANVS) (\u201cAnnovis\u201d or the \u201cCompany\u201d), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD), today announced that Maria Maccecchini, PhD, Founder, President and CEO of Annovis, will participate and present in two industry events in November. U.S. Biotech Day 2026 | November 16\u201317, 2026 | Philadelphia, PA Panel: \u201cBridging the Translational Gap: From Discovery Insights to Clinical Proof\u201d, November 16, 9:15\u20139:45 a.m. ET Company showcase: November 16, 10:15\u201310:30 a.m. ET At U.S. Biotech Day 2026, Dr. &hellip; Continue reading \"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-10-29T16:19:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026","datePublished":"2026-10-29T16:19:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/"},"wordCount":481,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/","name":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=","datePublished":"2026-10-29T16:19:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg1NTg5MCM3OTIyOTc3IzIxOTQ4NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/annovis-to-participate-in-u-s-biotech-day-2026-and-pharma-partnering-summit-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1015201"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1015201\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1015201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1015201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1015201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}